Pictet Asset Management (UK)’s Moderna MRNA Stock Holding History

Pictet Asset Management (UK)’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$67.2M	Sell	285,950 -20,291	-7%	-$3.63M	0.07%	292
2021 Q1	$40.1M	Buy	306,241 +34,301	+13%	+$4.97M	0.05%	373
2020 Q4	$28.4M	Buy	271,940 +144	+0.1%	+$14.6K	0.04%	418
2020 Q3	$19.2M	Buy	271,796 +165,843	+157%	+$11.6M	0.03%	434
2020 Q2	$6.8M	Sell	105,953 -77,899	-42%	-$4.27M	0.01%	616
2020 Q1	$5.51M	Sell	183,852 -103,284	-36%	-$2.38M	0.01%	618
2019 Q4	$5.62M	Sell	287,136 -20,361	-7%	-$361K	0.01%	736
2019 Q3	$4.89M	Sell	307,497 -356,957	-54%	-$5.27M	0.01%	701
2019 Q2	$9.73M	Buy	664,454 +19,097	+3%	+$410K	0.02%	531
2019 Q1	$13.1M	Sell	645,357 -115,663	-15%	-$2.15M	0.03%	477
2018 Q4	$11.6K	Buy	+761,020	New	+$12.5M	0.03%	470

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Pictet Asset Management (UK)'s MRNA Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Moderna (MRNA) stake by 6.6% in Q2 2021, selling an estimated $3.63M and leaving 285,950 shares worth $67.2M. The position accounts for 0.07% of the portfolio, ranked #292.

Pictet Asset Management (UK) first reported a position in MRNA in Q4 2018 and has held it in 11 quarters since. 903 funds tracked by Wall St. Rank hold MRNA as of Q2 2021.

Pictet Asset Management (UK) held 285,950 shares of Moderna worth $67.2M as of Q2 2021.
Pictet Asset Management (UK) sold 20,291 Moderna shares in Q2 2021, an estimated $3.63M.
Moderna made up 0.07% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #292 holding.
Pictet Asset Management (UK) first reported a position in Moderna in Q4 2018 and has held it in 11 quarters since.
903 funds tracked by Wall St. Rank held Moderna as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.